Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials

This meta-analysis assessed the efficacy and safety of novel β-lactam/β-lactamase inhibitor combinations in the treatment of complicated urinary tract infection (cUTI)/acute pyelonephritis (APN). PubMed, Web of Science, EBSCO (Elton B. Stephens Co.), Cochrane Library, Ovid MEDLINE, and Embase databa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2020-05, Vol.99 (19), p.e19960-e19960
Hauptverfasser:	Lu, Li-Chin, Lai, Chih-Cheng, Chang, Shen-Peng, Lan, Shao-Huan, Hung, Shun-Hsing, Lin, Wei-Ting
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology beta-Lactamase Inhibitors - pharmacology beta-Lactams - antagonists & inhibitors Drug Therapy, Combination - methods Humans Pyelonephritis - drug therapy Pyelonephritis - microbiology Randomized Controlled Trials as Topic Systematic Review and Meta-Analysis Treatment Outcome Urinary Tract Infections - drug therapy Urinary Tract Infections - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!